Morepen Laboratories Limited (BOM:500288)
61.16
+0.38 (0.63%)
At close: Jul 7, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 33.51 billion as of July 7, 2026. Its market cap has decreased by -5.70% in one year.
Market Cap
33.51B
Enterprise Value
34.68B
Revenue
18.06B
Ranking
n/a
PE Ratio
35.35
Stock Price
61.16
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 33.51B, an increase of 287.07%. That is a compound annual growth rate of 5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 33.51B | 48.92% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 70.54B |
| Bliss GVS Pharma | 53.55B |
| Gufic Biosciences | 39.21B |
| Novartis India | 36.27B |
| Unichem Laboratories | 33.32B |
| Kwality Pharmaceuticals | 27.77B |
| Hikal | 27.40B |
| Venus Remedies | 22.89B |